Is Down Syndrome a Mutation or Chromosomal Error?

Down syndrome is not a mutation in the traditional sense. It is a chromosomal abnormality, specifically a condition where a person has three copies of chromosome 21 instead of the usual two. While mutations typically involve changes to the DNA sequence within a gene, Down syndrome involves an entire extra chromosome or a large extra piece of one. In genetics, this distinction matters: Down syndrome is classified as aneuploidy, meaning an abnormal number of chromosomes, rather than a gene-level mutation.

Why the Distinction Matters

When most people think of a “mutation,” they picture a change in the letters of the genetic code, like swapping one DNA base for another or deleting a small segment. These kinds of changes can alter a single gene and the protein it produces. Down syndrome works differently. Instead of a misspelling in the genetic instructions, there’s a whole extra copy of an instruction manual. Chromosome 21 contains hundreds of genes, and having three copies instead of two means the body produces roughly 50% more of certain proteins encoded on that chromosome. This overproduction, called the gene dosage effect, is what drives the physical and developmental features of the condition.

Not all of those extra gene copies cause problems. Research published in Genetics in Medicine found that about 56% of the genes on the extra chromosome are naturally compensated for by the body, meaning their output stays close to normal levels. Around 22% are overexpressed at the expected 1.5-fold increase, and 7% are amplified even beyond that. It’s this smaller subset of overexpressed genes that appears responsible for specific features of Down syndrome, including certain heart defects and eye conditions.

Three Types of Chromosomal Error

Down syndrome occurs through one of three mechanisms, each involving chromosome 21 but in slightly different ways.

Nondisjunction (95% of cases): During cell division, chromosome pairs are supposed to split evenly so each new cell gets one copy. In nondisjunction, both copies of chromosome 21 end up in the same cell instead of separating. The result is an egg or sperm with two copies of chromosome 21. After fertilization, the embryo has three. This is a random error in cell division, not something inherited from a parent’s DNA.

Translocation (3% to 4% of cases): A piece of chromosome 21 breaks off and attaches to another chromosome. The person still has extra chromosome 21 material in every cell, but their total chromosome count may appear normal at first glance. This is the only form that can be inherited. A parent can carry a “balanced translocation,” meaning their chromosomes are rearranged but they have no extra genetic material and no symptoms. They can, however, pass an unbalanced version to their children, resulting in Down syndrome.

Mosaicism (1% to 2% of cases): The cell division error happens after fertilization, so only some of the body’s cells end up with three copies of chromosome 21 while others have the typical two. People with mosaic Down syndrome may have milder features, depending on how many cells are affected and where they are in the body.

What Causes the Cell Division Error

The vast majority of Down syndrome cases are not inherited. They result from a random mistake during the formation of an egg or sperm cell. The strongest known risk factor is maternal age at conception. A 25-year-old woman has roughly a 1 in 1,300 chance of having a baby with Down syndrome. By age 35, that risk rises to about 1 in 365. At 45, it jumps to approximately 1 in 30. The reasons for this age-related increase likely involve the aging of egg cells, which have been paused mid-division since before a woman was born and become more prone to errors in chromosome separation over time.

That said, most babies with Down syndrome are born to women under 35, simply because younger women have far more pregnancies overall. Paternal age may also play a small role, though the association is much weaker.

How It Is Detected

Prenatal testing for Down syndrome falls into two categories. Screening tests estimate the likelihood that a fetus has the condition but cannot confirm it. These include blood tests that analyze fragments of fetal DNA circulating in the mother’s bloodstream, often called noninvasive prenatal testing. A positive screen means further testing is recommended, not that the diagnosis is certain.

Diagnostic tests, by contrast, provide a definitive answer. Chorionic villus sampling can be performed between weeks 9 and 11 of pregnancy by taking a small sample of placental cells. Amniocentesis, done between weeks 14 and 18, tests a sample of the fluid surrounding the fetus. Both look directly at the fetal chromosomes to confirm whether an extra copy of chromosome 21 is present. After birth, a simple blood test called a karyotype can map all 46 (or 47) chromosomes and confirm the diagnosis.

How Extra Genes Affect the Body

The extra genetic material from chromosome 21 influences development in ways that vary significantly from person to person. Common features include some degree of intellectual disability, distinct facial characteristics, and lower muscle tone in infancy. About half of babies born with Down syndrome have a heart defect, likely linked to overexpression of specific genes on chromosome 21 that influence heart tissue development. Vision and hearing problems are also more common, and thyroid function should be monitored regularly.

The range of outcomes is wide. Some individuals live independently, hold jobs, and attend college. Others need more substantial daily support. Early intervention programs, including speech therapy, physical therapy, and educational support, have a meaningful impact on long-term development.

Life Expectancy Has Changed Dramatically

In 1960, the average life expectancy for a person with Down syndrome was about 10 years, largely due to untreated heart defects and limited medical care. By 2007, that figure had risen to about 47 years. Advances in cardiac surgery, better management of associated health conditions, and improved social inclusion have all contributed. In the United States, about 5,700 babies are born with Down syndrome each year, roughly 1 in every 640 births.